Totally disagree with the first sentence; totally agree with the 2nd two and the earlier opinion of Stomer re the board. Great former CEO - hit every milestone on time every time. That's why the investors were there and not there now. The science remains solid and undiminished, primary target directed against a very real unmet healthcare need for an awful disease. Current and future IPF sufferers are the real losers here.
1AD Price at posting:
8.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)